# Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

> **NCT00037011** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** beta-glucan
- **BIOLOGICAL:** monoclonal antibody 3F8

## Key facts

- **NCT ID:** NCT00037011
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2005-01
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00037011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00037011, "Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00037011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*